Swarali Tadwalkar
Principal Consultant
Swarali has over 9 years of experience in providing consultancy support for the design and implementation of market sizing, epidemiology and real-world studies. Swarali has led multiple projects across a wide array of therapy areas, including rare diseases, oncology, and metabolic disorders. Swarali acts as a project lead/manager for projects involving data collation, epidemiology analysis, market sizing strategies, data forecasting and deriving insights from various real-world data assets. She supports clients in various aspects, such as developing strategies to understand disease market, meeting preparation and development of evidence dossiers/briefing books for FDA/EMA submissions. Throughout her career, she has developed a strong interest in tackling data challenges for analyzing complex disease indications and deriving robust insights especially for rare diseases.
Swarali has presented epidemiology forecasts and results from real-world data studies at various conferences, including, the World Cancer Congress and the Indian Cancer Congress. She holds an MPH degree from the University of South Florida, Tampa specializing in Epidemiology and Biostatistics and a BE in Biotechnology from the University of Mumbai.
Latest news
Clarivate Launches Derwent Patent Monitor to Enable Fast and Accurate Decision-making with AI
New enterprise solution streamlines IP and R&D patent reviews and accelerates freedom to operate, patentability, and infringement related decisions London, U.K. November 24, 2025. Clarivate Plc (NYSE:CLVT), a leading global provider…
Clarivate RiskMark Wins 2025 LegalTech Breakthrough Award For “LegalTech Predictive AI Solution of the Year”
Annual awards program recognizes companies and products driving innovation in the global legal technology industry AI-powered RiskMark delivers near-instant, data-backed insights London, U.K. November 13, 2025. Clarivate Plc (NYSE:CLVT), a…
